Back to results
US 2022/0016055 A1Published application
Pharmaceutical Compositions For Combination Therapy
AssigneeSaniona A/S
InventorsHenrik Bjork Hansen, Morten Grunnet, Bo Hjorth Bentzen, Lars Hyveled-Nielsen, Jorgen Buus Lassen, Claus Sundgreen
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected.
Claims13
A method of inducing hypophagia in a human comprising:
- administering 0.1 mg to 1 mg of Tesofensine, or a pharmaceutically acceptable salt thereof, to the human, daily;
- in combination with 25 mg to 200 mg of Metoprolol, or a pharmaceutically acceptable salt thereof, daily,
- wherein the combination is effective in inducing hypophagia and wherein the combination is effective in preventing or alleviating drug-induced cardiovascular side-effects.
Dependencies are inferred from the claim text.